Zelda Euler

Complex-type <i>N</i> -glycan recognition by potent broadly neutralizing HIV antibodies

Hugo Mouquet, Louise Scharf, Zelda Euler et al. · Proceedings of the National Academy of Sciences · 2012 · 564 citations · Full text

Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

Dan H. Barouch, Frank Tomaka, Frank Wegmann et al. · The Lancet · 2018 · 334 citations · Full text

Vaccination, Vaccine Development, Nhp 13-19 +9

Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression

Zelda Euler, Marit J. van Gils, Evelien M. Bunnik et al. · The Journal of Infectious Diseases · 2010 · 167 citations · Full text

Primary Immunodeficiency, Disease Progression, Human Retrovirus +14

The Development of CD4 Binding Site Antibodies during HIV-1 Infection

Rebecca M. Lynch, Lillian Tran, Mark K. Louder et al. · Journal of Virology · 2012 · 136 citations · Full text

Adaptation of HIV-1 envelope gp120 to humoral immunity at a population level

Evelien M. Bunnik, Zelda Euler, Matthijs R. A. Welkers et al. · Nature Medicine · 2010 · 124 citations · Full text

Hiv-1 Envelope Gp120, Human Retrovirus, Humoral Response +9